Endeavor BioMedicines Competitors and Similar CompaniesClear all
Endeavor BioMedicines's competitors and similar companies include Novartis, Moderna, Regeneron Pharmaceuticals and Hutchison China Meditech.
 Endeavor BioMedicines Endeavor BioMedicines is a clinical-stage biotechnology company that develops new treatments targeting the underlying causes of pulmonary fibrosis. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Moderna Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine. |  Regeneron Pharmaceuticals Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines. |  Hutchison China Meditech Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products. | |
Founding Date | Founding Date 2018 | Founding Date 1996 | Founding Date 2010 | Founding Date 1988 | Founding Date 2000 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Tarrytown, US HQ Mississauga, CA Courbevoie, FR München, DE Bengaluru, IN Dublin, IE Limerick, IE see more | Locations Shanghai, CN HQ Beijing, CN Jiangsu, CN Shanghai, CN Shanghai, CN Hong Kong, HK Hong Kong, HK see more | |
Employees | Employees 482% increase | Employees 75,883 | Employees 5,8004% increase | Employees 15,1068% increase | Employees 1,811 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 21.2 b | Valuation ($) 102.2 b | Valuation ($) 3.6 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $1.9b (FY, 2025) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) $548.5m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $8.4b (FY, 2025) | Cost of goods $868m (FY, 2025) | Cost of goods N/A | Cost of goods $324.4m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $49.8b (FY, 2025) | Gross profit $1.1b (FY, 2025) | Gross profit N/A | Gross profit $224.2m (FY, 2025) |
Net income | Net income N/A | Net income $14b (FY, 2025) | Net income ($2.8b) (FY, 2025) | Net income $4.5b (FY, 2025) | Net income $435.1m (FY, 2025) |
Operating ⚠ | |||||
Patents (US) | Patents (US) N/A | Patents (US) N/A | Patents (US) 170 (FY, 2021) | Patents (US) 31 (FY, 2020) | Patents (US) N/A |
Funding | |||||
Total funding raised | Total funding raised $ 62m | Total funding raised $ 6.5m | Total funding raised $ 1.8b | Total funding raised $ 53.9m | Total funding raised $ 100m |
For sources of this data, please see the company profile
View Company Profiles
Novartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyModerna
HQ
Cambridge, US
Employees
5,800↑ 4% increase
Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.
View companyRegeneron Pharmaceuticals
HQ
Tarrytown, US
Employees
15,106↑ 8% increase
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
View companyHutchison China Meditech
HQ
Shanghai, CN
Employees
1,811
Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products.
View company